Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05724836 · ClinicalTrials.gov registry record
Prospective Carotid Artery Stenosis Trial
A clinical trial of Patients With Any Degree of Carotid Artery Stenosis and Vulnerable Features in the Carotid Artery Plaque, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT05724836: Recruiting study of Patients With Any Degree of Carotid Artery Stenosis and Vulnerable Features in the Carotid Artery Plaque, sponsored by Mayo Clinic.
NCT05724836 is a study of Patients With Any Degree of Carotid Artery Stenosis and Vulnerable Features in the Carotid Artery Plaque that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05724836, a study of Patients With Any Degree of Carotid Artery Stenosis and Vulnerable Features in the Carotid Artery Plaque, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers are collecting information and blood from subjects undergoing carotid artery interventions.
Primary Outcome
Number of biospecimens collected
Conditions Studied
Study Locations (1)
Florida
- Mayo Clinic Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-04-12 |
| Est. Completion | 2030-12 |
What NCT05724836 shows while recruiting
NCT05724836 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Patients With Any Degree of Carotid Artery Stenosis and Vulnerable Features in the Carotid Artery Plaque appearing as the primary indexed condition, and to 0 interventions.
NCT05724836 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05724836 about?
NCT05724836 is a clinical study titled "Prospective Carotid Artery Stenosis Trial". Researchers are collecting information and blood from subjects undergoing carotid artery interventions.
What is the current status of trial NCT05724836?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2023-04-12. Estimated completion is 2030-12.
What conditions does trial NCT05724836 study?
This clinical trial studies the following conditions: Patients With Any Degree of Carotid Artery Stenosis and Vulnerable Features in the Carotid Artery Plaque.
Who is sponsoring clinical trial NCT05724836?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05724836 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI